This study is looking into whether butyrate enemas can help children and young adults with mild to moderate ulcerative colitis (a chronic inflammatory bowel disease). Butyrate is a natural substance made by gut bacteria that has shown promise in treating ulcerative colitis. Researchers will give butyrate enemas once a day for 12 weeks to 10 participants aged 7 to 21. The main goal is to see how many participants have an ulcerative colitis activity score less than 10 after 12 weeks, which would suggest their condition has improved. This is a feasibility study, meaning it's testing if this treatment approach is practical and shows potential. The current status of this study is unclear.

Study design

This is an interventional study with a planned enrollment of 10 participants. It is testing butyrate enemas in children and young adults with ulcerative colitis.

What's involved

Participants will receive butyrate enemas once a day for 12 weeks. Standard management of the disease, including routine lab tests and endoscopy, will also be performed during this time.

Compensation

Not stated in the trial record.

Follow-up

The primary outcome is measured at 12 weeks, which is the duration of the treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.